Search Results - "Romero‐Palacián, Daniel"

Tocilizumab‐Associated Reversible Cerebral Vasoconstriction: A Case Report by Gonzalez‐Martinez, Alicia, Romero‐Palacián, Daniel, Dotor García‐Soto, Julio, Sánchez, Pedro, Reig Roselló, Gemma, Zapata Wainberg, Gustavo

“…Objectives To report a case of reversible cerebral vasoconstriction syndrome (RCVS) possibly precipitated by tocilizumab. Background Immunosuppressant drugs…”
Get full text

Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure by Saiz‐Rodríguez, Miriam, Romero‐Palacián, Daniel, Villalobos‐Vilda, Carlos, Caniego, José Luis, Belmonte, Carmen, Koller, Dora, Bárcena, Eduardo, Talegón, María, Abad‐Santos, Francisco

“…This observational retrospective study assessed the antiplatelet response and clinical events after clopidogrel treatment in patients who underwent…”
Get full text

Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial by Koller, Dora, Almenara, Susana, Mejía, Gina, Saiz‐Rodríguez, Miriam, Zubiaur, Pablo, Román, Manuel, Ochoa, Dolores, Wojnicz, Aneta, Martín, Samuel, Romero‐Palacián, Daniel, Navares‐Gómez, Marcos, Abad‐Santos, Francisco

“…Objective To assess adverse events (AEs) and safety of aripiprazole (ARI) and olanzapine (OLA) treatment. Methods Twenty‐four healthy volunteers receiving five…”
Get full text

The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple‐dose trial by Koller, Dora, Saiz‐Rodríguez, Miriam, Zubiaur, Pablo, Ochoa, Dolores, Almenara, Susana, Román, Manuel, Romero‐Palacián, Daniel, Miguel‐Cáceres, Alejandro, Martín, Samuel, Navares‐Gómez, Marcos, Mejía, Gina, Wojnicz, Aneta, Abad‐Santos, Francisco

“…Aims Pupillography is a noninvasive and cost‐effective method to determine autonomic nerve activity. Genetic variants in cytochrome P450 (CYP), dopamine…”
Get full text

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention by Saiz-Rodríguez, Miriam, Belmonte, Carmen, Caniego, José Luis, Koller, Dora, Zubiaur, Pablo, Bárcena, Eduardo, Romero-Palacián, Daniel, Eugene, Andy R., Ochoa, Dolores, Abad-Santos, Francisco

“…Clopidogrel is a thienopyridine prodrug that inhibits platelet aggregation. It is prescribed to prevent atherothrombotic and thromboembolic events in patients…”
Get full text